Targeted therapy for triple-negative breast cancer
Dual target of EGFR and mTOR suppresses triple-negative breast cancer cell growth by regulating the phosphorylation of mTOR downstream proteins. Read more...
Source: dovepress.com
Stay updated with breaking news from Pathological Features. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dual target of EGFR and mTOR suppresses triple-negative breast cancer cell growth by regulating the phosphorylation of mTOR downstream proteins. Read more...
Study of survival prediction model for Mucinous carcinoma of Breast patients; MCB being a rare malignant tumour.